2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 31444999 | Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma. | 2019 Oct | 1 |
| 2 | 30572654 | Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth. | 2018 Dec 19 | 1 |